Samjin Pharmaceuticals Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010
Net Income	21,894	28,404	10,638	7,062	10,477
Depreciation & Amortization	9,816	7,360	-	3,242	2,889
Loss (Gain) From Sale of Assets	-504	-1,038	-	19.65	-149.96
Asset Writedown & Restructuring Costs	-0.5	-39.33	-	74.48	4,460
Loss (Gain) From Sale of Investments	-2,920	-	-	-	717.2
Loss (Gain) on Equity Investments	304.34	25.79	-	-	-
Provision & Write-off of Bad Debts	184.31	442.79	-	1,487	2,017
Other Operating Activities	1,026	8,739	10,144	2,167	6,178
Change in Accounts Receivable	-3,293	-5,818	-	1,145	-8,250
Change in Inventory	1,115	355.99	-	936.92	-1,873
Change in Accounts Payable	944.25	-473.87	-	-557.08	2,257
Change in Unearned Revenue	71.26	-	-	-	-
Change in Income Taxes	-	-	-	-	3,565
Change in Other Net Operating Assets	-11,344	-13,991	13,149	-2,907	-5,049
Operating Cash Flow	17,293	23,967	33,932	12,670	16,836
Operating Cash Flow Growth	-27.85%	-29.37%	167.80%	-24.74%	688.41%
Capital Expenditures	-35,354	-72,549	-12,654	-11,352	-3,914
Sale of Property, Plant & Equipment	53.22	1,656	19.04	30.91	150
Cash Acquisitions	-29,554	-	-	-	-
Sale (Purchase) of Intangibles	-143.82	-1,676	-50.47	-213.91	-581.24
Sale (Purchase) of Real Estate	570.41	11.6	-	-	-
Investment in Securities	-5,989	1,002	-4,980	-336.83	-1,343
Other Investing Activities	359.43	-	0.1	-142.04	885.14
Investing Cash Flow	-70,057	-71,555	-17,665	-12,014	-4,803
Short-Term Debt Issued	67,000	22,000	7,360	107,440	60,190
Long-Term Debt Issued	11,000	37,600	-	-	6,000
Total Debt Issued	78,000	59,600	7,360	107,440	66,190
Short-Term Debt Repaid	-41,000	-12,000	-5,800	-96,000	-64,490
Long-Term Debt Repaid	-4,799	-1,439	-3,000	-8,000	-14,000
Total Debt Repaid	-45,799	-13,439	-8,800	-104,000	-78,490
Net Debt Issued (Repaid)	32,201	46,161	-1,440	3,440	-12,300
Issuance of Common Stock	30,000	-	-	-	-
Repurchase of Common Stock	-4,993	-	-11,982	-2,230	-36.76
Common Dividends Paid	-	-	-2,863	-640.82	-373.18
Dividends Paid	-9,842	-9,842	-2,863	-640.82	-373.18
Other Financing Activities	-200	300	170.18	-79	62.51
Financing Cash Flow	47,165	36,619	-16,115	490.57	-12,647
Miscellaneous Cash Flow Adjustments	0	0	-	-	-
Net Cash Flow	-5,599	-10,969	152.23	1,147	-614.94
Free Cash Flow	-18,061	-48,581	21,278	1,318	12,921
Free Cash Flow Growth	-	-	1514.09%	-89.80%	-
Free Cash Flow Margin	-6.59%	-19.43%	11.46%	0.65%	6.45%
Free Cash Flow Per Share	-1425.33	-3948.80	1634.08	101.17	977.60
Cash Interest Paid	2,109	592.7	1,773	2,345	-
Cash Income Tax Paid	7,153	3,717	4,208	16,499	-
Levered Free Cash Flow	-11,924	-	13,556	10,209	9,799
Unlevered Free Cash Flow	-10,822	-	14,662	11,729	11,488
Change in Working Capital	-12,507	-19,927	13,149	-1,382	-9,753

Updated Nov 14, 2013. Source: S&P Global Market Intelligence. Standard template. Financial Sources.